Concourse Financial Group Securities’s QuidelOrtho QDEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-1
Closed -$44 1572
2024
Q4
$44 Sell
1
-1
-50% -$41 ﹤0.01% 2229
2024
Q3
$91 Sell
2
-4
-67% -$162 ﹤0.01% 2205
2024
Q2
$199 Hold
6
﹤0.01% 2253
2024
Q1
$287 Hold
6
﹤0.01% 2251
2023
Q4
$442 Buy
+6
New +$406 ﹤0.01% 2191
2023
Q2
Sell
-152
Closed -$13.3K 2432
2023
Q1
$13.5K Sell
152
-1,355
-90% -$118K ﹤0.01% 1583
2022
Q4
$129K Buy
1,507
+152
+11% +$12.9K 0.01% 757
2022
Q3
$97K Buy
1,355
+589
+77% +$52.7K 0.01% 734
2022
Q2
$74K Buy
+766
New +$78.1K 0.01% 929
2021
Q2
Sell
-28
Closed -$3.3K 2425
2021
Q1
$4K Sell
28
-24
-46% -$4.43K ﹤0.01% 2023
2020
Q4
$9K Sell
52
-126
-71% -$28K ﹤0.01% 1729
2020
Q3
$39K Buy
178
+155
+674% +$34.6K ﹤0.01% 1161
2020
Q2
$5K Buy
+23
New +$3.6K ﹤0.01% 1697

Other funds holding QDEL

Concourse Financial Group Securities's QDEL Position: Q1 2025 in Review

Concourse Financial Group Securities sold out of QuidelOrtho (QDEL) in Q1 2025, closing a stake of 1 share — an estimated $44 sold.

Concourse Financial Group Securities first reported a position in QDEL in Q2 2020 and held it in 13 quarters. The position peaked at $129K in Q4 2022. 266 funds tracked by Wall St. Rank hold QDEL as of Q1 2025.

  • Concourse Financial Group Securities reported no remaining QuidelOrtho position as of Q1 2025 after selling out during the quarter.
  • Concourse Financial Group Securities sold 1 QuidelOrtho share in Q1 2025, an estimated $44.
  • Concourse Financial Group Securities first reported a position in QuidelOrtho in Q2 2020 and held it in 13 quarters.
  • Concourse Financial Group Securities's QuidelOrtho position peaked at $129K in Q4 2022.
  • 266 funds tracked by Wall St. Rank held QuidelOrtho as of Q1 2025.

Based on Concourse Financial Group Securities's 13F filing for Q1 2025.